Carl W Porter

Roswell Park Cancer Institute Corp

$5,047,582

Attributed

$5,047,582

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $743.6K · FY2005–07

$1M$750K$500K$250K$0

'05

'06

'07

Funding mix

By agency

NIH$5,047,582 · 2

By mechanism

R01$5,047,582 · 2

Top collaborators

No co-investigators on record.

Most similar at Roswell Park Cancer Institute Corp

Same institution · by research overlap

Wei Zheng$71,826,577
Kenneth Michael Cummings$7,969,251
Xiang-Yang Wang$11,998,946
John David Carpten$9,472,293
Scott I. Abrams$11,133,748

Others in their field

Top investigators on “Spermidine”

Margaret A. Phillips · Ut Southwestern Medical Center$10,818,768
Keith T Wilson · Vanderbilt University Medical Center$10,043,965
Robert A Casero · Michigan State University$5,914,538
Steven E Ealick · Hauptman-Woodward Medical Research Inst$4,915,798
Buddy Ullman · Oregon Health And Science University$4,468,290
Raymond J Bergeron · University Of Florida$4,215,824

Research focus

SpermidinePolyaminesAntineoplasticsNeoplastic CellPharmacokineticsApoptosisMelanomaAnalogP53 Gene /ProteinCell ProliferationAthymic MouseCell CycleTissue /Cell CultureHuman TissueOncoprotein P21Laboratory MouseEnzyme ActivitySpermineMolecular GeneticsCell Growth RegulationAcyltransferaseProtein Structure FunctionEnzyme Induction /RepressionDecarboxylase Inhibitor